{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T06:43:19Z","timestamp":1792478599270,"version":"4.5.0"},"reference-count":83,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2026.15857","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T11:37:58Z","timestamp":1789126678000},"page":"1-16","source":"Crossref","is-referenced-by-count":0,"title":["Effect of extracellular vesicles on malignant tumours: Mechanisms and clinical findings (Review)"],"prefix":"10.3892","volume":"32","author":[{"given":"Ruiyi","family":"Shen","sequence":"first","affiliation":[{"name":"Graduate School, Integrated Chinese and Western Medicine Institute for Children Health and Drug Innovation, Jiangxi University of Chinese Medicine, Nanchang, Jiangxi 330004, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qihong","family":"Lan","sequence":"additional","affiliation":[{"name":"Graduate School, Integrated Chinese and Western Medicine Institute for Children Health and Drug Innovation, Jiangxi University of Chinese Medicine, Nanchang, Jiangxi 330004, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Lu","sequence":"additional","affiliation":[{"name":"Graduate School, Integrated Chinese and Western Medicine Institute for Children Health and Drug Innovation, Jiangxi University of Chinese Medicine, Nanchang, Jiangxi 330004, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Wen","sequence":"additional","affiliation":[{"name":"Graduate School, Integrated Chinese and Western Medicine Institute for Children Health and Drug Innovation, Jiangxi University of Chinese Medicine, Nanchang, Jiangxi 330004, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhen","family":"Wei","sequence":"additional","affiliation":[{"name":"Graduate School, Integrated Chinese and Western Medicine Institute for Children Health and Drug Innovation, Jiangxi University of Chinese Medicine, Nanchang, Jiangxi 330004, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Liu","sequence":"additional","affiliation":[{"name":"Graduate School, Integrated Chinese and Western Medicine Institute for Children Health and Drug Innovation, Jiangxi University of Chinese Medicine, Nanchang, Jiangxi 330004, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"key":"key20261020093210_b1-ol-32-5-15857","first-page":"1","article-title":"The global challenge of cancer","volume":"1","year":"2020","journal-title":"Nat Cancer"},{"key":"key20261020093210_b2-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"216","DOI":"10.2478\/ebtj-2025-0018","article-title":"Messaging malignancy: Tumour-derived exosomes at the nexus of immune escape, vascular remodelling and metastatic competence","volume":"9","author":"Yildirim","year":"2025","journal-title":"EuroBiotech J"},{"key":"key20261020093210_b3-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"112150","DOI":"10.1016\/j.intimp.2024.112150","article-title":"Extracellular vesicles derived from immune cells: Role in tumor therapy","volume":"133","author":"Shi","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"key20261020093210_b4-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s44222-024-00255-5","article-title":"The physico-chemical landscape of extracellular vesicles","volume":"3","author":"Manno","year":"2025","journal-title":"Nat Rev Bioeng"},{"key":"key20261020093210_b5-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1194\/jlr.E086173","article-title":"Extracellular vesicles: Lipids as key components of their biogenesis and functions","volume":"59","author":"Record","year":"2018","journal-title":"J Lipid Res"},{"key":"key20261020093210_b6-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41392-024-01735-1","article-title":"Extracellular vesicles as tools and targets in therapy for diseases","volume":"9","author":"Kumar","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"key20261020093210_b7-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"1548535","DOI":"10.3389\/fimmu.2025.1548535","article-title":"Tumor-derived extracellular vesicles: Key drivers of immunomodulation in breast cancer","volume":"16","author":"Li","year":"2025","journal-title":"Front Immunol"},{"key":"key20261020093210_b8-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"105041","DOI":"10.1016\/j.phrs.2020.105041","article-title":"Tumor-derived extracellular vesicles: Regulators of tumor microenvironment and the enlightenment in tumor therapy","volume":"159","author":"Chen","year":"2020","journal-title":"Pharmacol Res"},{"key":"key20261020093210_b9-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"e2417357","DOI":"10.1002\/advs.202417357","article-title":"Effect of extracellular vesicles derived from tumor cells on immune evasion","volume":"12","author":"Liu","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"key20261020093210_b10-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/s41568-024-00752-0","article-title":"Cancer-induced systemic pre-conditioning of distant organs: Building a niche for metastatic cells","volume":"24","author":"Rabas","year":"2024","journal-title":"Nat Rev Cancer"},{"key":"key20261020093210_b11-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.cell.2020.02.001","article-title":"The role and prospects of extracellular vesicles in advanced drug and vaccine delivery. Front Immunol 17: 1781365, 2026. Zhao Z, Ukidve A, Kim J and Mitragotri S: Targeting strategies for tissue-specific drug delivery","volume":"181","author":"Huang","year":"2020","journal-title":"Cell"},{"key":"key20261020093210_b12-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.bbcan.2017.11.005","article-title":"The key role of extracellular vesicles in the metastatic process","volume":"1869","author":"Zhao","year":"2018","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"key20261020093210_b13-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s40005-025-00774-2","article-title":"Fusion nanoparticle system of extracellular vesicles and docetaxel-loaded liposomes: An innovative therapeutic strategy to enhance anticancer efficacy","volume":"56","author":"Asadujjaman","year":"2026","journal-title":"J Pharm Investig"},{"key":"key20261020093210_b14-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ccell.2019.01.007","article-title":"Integrin signaling in cancer: Mechanotransduction, stemness, epithelial plasticity, and therapeutic resistance","volume":"35","author":"Cooper","year":"2019","journal-title":"Cancer Cell"},{"key":"key20261020093210_b15-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"106669","DOI":"10.1016\/j.phrs.2023.106669","article-title":"Formation of pre-metastatic niches induced by tumor extracellular vesicles in lung metastasis","volume":"188","author":"Liu","year":"2023","journal-title":"Pharmacol Res"},{"key":"key20261020093210_b16-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"663978","DOI":"10.3389\/fphys.2021.663978","article-title":"Matrix metalloproteinase 3: A promoting and destabilizing factor in the pathogenesis of disease and cell differentiation","volume":"12","author":"Wan","year":"2021","journal-title":"Front Physiol"},{"key":"key20261020093210_b17-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1016\/j.bbamcr.2017.05.027","article-title":"Metalloproteinases in extracellular vesicles","volume":"1864","author":"Shimoda","year":"2017","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"key20261020093210_b18-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"e35063","DOI":"10.1016\/j.heliyon.2024.e35063","article-title":"Extracellular vesicles and macrophages in tumor microenvironment: Impact on cervical cancer","volume":"10","author":"Guo","year":"2024","journal-title":"Heliyon"},{"key":"key20261020093210_b19-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"e70018","DOI":"10.1111\/boc.70018","article-title":"Protrusion-derived extracellular vesicles (PD-EVs) and their diverse origins: Key players in cellular communication, cancer progression, and T cell modulation","volume":"117","author":"Duro","year":"2025","journal-title":"Biol Cell"},{"key":"key20261020093210_b20-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12964-023-01338-3","article-title":"Integrin\u03b2-1 in disorders and cancers: Molecular mechanisms and therapeutic targets","volume":"22","author":"Su","year":"2024","journal-title":"Cell Commun Signal"},{"key":"key20261020093210_b21-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"108458","DOI":"10.1016\/j.pharmthera.2023.108458","article-title":"Integrins in cancer: Emerging mechanisms and therapeutic opportunities","volume":"247","author":"Liu","year":"2023","journal-title":"Pharmacol Ther"},{"key":"key20261020093210_b22-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1186\/s12967-023-04696-1","article-title":"The characteristics and the multiple functions of integrin \u03b21 in human cancers","volume":"21","author":"Sun","year":"2023","journal-title":"J Transl Med"},{"key":"key20261020093210_b23-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.1038\/s41467-026-70600-2","article-title":"Vascular invasion-associated gene expression is detectable in pre-surgical biopsies of stage I lung adenocarcinoma","volume":"17","author":"Steiner","year":"2026","journal-title":"Nat Commun"},{"key":"key20261020093210_b24-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"e12125","DOI":"10.1002\/jev2.12125","article-title":"Extracellular vesicles in the development of organ-specific metastasis","volume":"10","author":"Urabe","year":"2021","journal-title":"J Extracell Vesicles"},{"key":"key20261020093210_b25-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1186\/s12967-025-06526-y","article-title":"Invadopodia in cancer metastasis: Dynamics, regulation, and targeted therapies","volume":"23","author":"Hao","year":"2025","journal-title":"J Transl Med"},{"key":"key20261020093210_b26-ol-32-5-15857","first-page":"451","article-title":"Immune checkpoint inhibitors: Breakthroughs in cancer treatment","volume":"21","author":"Kong","year":"2024","journal-title":"Cancer Biol Med"},{"key":"key20261020093210_b27-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"4113","DOI":"10.1016\/j.ymthe.2025.05.038","article-title":"Cancer-derived extracellular vesicles in natural killer cell immune evasion: Molecular mechanisms and therapeutic insights","volume":"33","author":"Coleborn","year":"2025","journal-title":"Mol Ther"},{"key":"key20261020093210_b28-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12943-018-0913-y","article-title":"Effects of tumor metabolic microenvironment on regulatory T cells","volume":"17","author":"Wang","year":"2018","journal-title":"Mol Cancer"},{"key":"key20261020093210_b29-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/s41586-018-0392-8","article-title":"Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response","volume":"560","author":"Chen","year":"2018","journal-title":"Nature"},{"key":"key20261020093210_b30-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"e1270","DOI":"10.1002\/cti2.1270","article-title":"TGF-\u03b2-secreting regulatory B cells: Unsung players in immune regulation","volume":"10","author":"Huai","year":"2021","journal-title":"Clin Transl Immunology"},{"key":"key20261020093210_b31-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.3390\/diagnostics13172769","article-title":"SMAD proteins in TGF-\u03b2 signalling pathway in cancer: Regulatory mechanisms and clinical applications","volume":"13","author":"Wang","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"key20261020093210_b32-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"15870","DOI":"10.1038\/s41598-026-43324-y","article-title":"PD-L1-positive circulating tumor cells associate with tumor malignancy and impaired circulating immunity in patients with gastrointestinal tumors","volume":"16","author":"Kusterer","year":"2026","journal-title":"Sci Rep"},{"key":"key20261020093210_b33-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/s41392-025-02280-1","article-title":"Immune evasion in cancer: Mechanisms and cutting-edge therapeutic approaches","volume":"10","author":"Tufail","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"key20261020093210_b34-ol-32-5-15857","first-page":"756","article-title":"Role and mechanisms of angiogenesis in tumours","volume":"14","author":"Sobczy\u0144ska-Rak","year":"2025","journal-title":"Biology (Basel)"},{"key":"key20261020093210_b35-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.1111\/jcmm.16359","article-title":"Extracellular vesicle-mediated regulation of tumor angiogenesis-implications for anti-angiogenesis therapy","volume":"25","author":"Zhang","year":"2021","journal-title":"J Cell Mol Med"},{"key":"key20261020093210_b36-ol-32-5-15857","first-page":"694905","article-title":"Large extracellular vesicles regulate endothelial angiogenic potential via paracrine and autocrine signaling","volume":"12","author":"Richmond","year":"2025","journal-title":"bioRxiv [Preprint]"},{"key":"key20261020093210_b37-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1038\/s41417-023-00638-7","article-title":"Small extracellular vesicle TGF-\u03b2 in cancer progression and immune evasion","volume":"30","author":"Hosseini","year":"2023","journal-title":"Cancer Gene Ther"},{"key":"key20261020093210_b38-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"104579","DOI":"10.1016\/j.jddst.2023.104579","article-title":"Engineered exosomes for cancer theranostics: Next-generation tumor targeting","volume":"85","author":"Chavda","year":"2023","journal-title":"J Drug Deliv Sci Technol"},{"key":"key20261020093210_b39-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/j.jconrel.2023.11.057","article-title":"Extracellular vesicles and their engineering strategies, delivery systems, and biomedical applications","volume":"365","author":"Yang","year":"2024","journal-title":"J Control Release"},{"key":"key20261020093210_b40-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.3748\/wjg.v10.i17.2524","article-title":"Angiogenic synergistic effect of basic fibroblast growth factor and vascular endothelial growth factor in an in vitro quantitative microcarrier-based three-dimensional fibrin angiogenesis system","volume":"10","author":"Sun","year":"2004","journal-title":"World J Gastroenterol"},{"key":"key20261020093210_b41-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1177\/1947601911423031","article-title":"Vascular endothelial growth factor (VEGF) and its receptor (VEGFR) signaling in angiogenesis: A crucial target for anti- and pro-angiogenic therapies","volume":"2","author":"Shibuya","year":"2011","journal-title":"Genes Cancer"},{"key":"key20261020093210_b42-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1007\/s12035-020-01892-8","article-title":"Tumor development and angiogenesis in adult brain tumor: Glioblastoma","volume":"57","author":"Ahir","year":"2020","journal-title":"Mol Neurobiol"},{"key":"key20261020093210_b43-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1001\/jamaoncol.2016.0097","article-title":"A novel urine exosome gene expression assay to predict high-grade prostate cancer at initial biopsy","volume":"2","author":"McKiernan","year":"2016","journal-title":"JAMA Oncol"},{"key":"key20261020093210_b44-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"109612","DOI":"10.1016\/j.isci.2024.109612","article-title":"Extracellular vesicles-derived CXCL4 is a candidate serum tumor biomarker for colorectal cancer","volume":"27","author":"Xie","year":"2024","journal-title":"iScience"},{"key":"key20261020093210_b45-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.3390\/biomedicines13102353","article-title":"MicroRNAs in BM-MSC-derived extracellular vesicles promote angiogenesis: An in vitro model study","volume":"13","author":"Kusakabe","year":"2025","journal-title":"Biomedicines"},{"key":"key20261020093210_b46-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1038\/s12276-021-00651-6","article-title":"Plasma extracellular vesicle delivery of miR-210-3p by targeting ATG7 to promote sepsis-induced acute lung injury by regulating autophagy and activating inflammation","volume":"53","author":"Li","year":"2021","journal-title":"Exp Mol Med"},{"key":"key20261020093210_b47-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/s41392-024-02021-w","article-title":"Liquid biopsy in cancer: Current status, challenges and future prospects","volume":"9","author":"Ma","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"key20261020093210_b48-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41392-025-02249-0","article-title":"Vascular endothelial growth factor signaling in health and disease: From molecular mechanisms to therapeutic perspectives","volume":"10","author":"Lee","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"key20261020093210_b49-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/s41392-023-01460-1","article-title":"Angiogenic signaling pathways and anti-angiogenic therapy for cancer","volume":"8","author":"Liu","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"key20261020093210_b50-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"116783","DOI":"10.1016\/j.biopha.2024.116783","article-title":"Survival strategies: How tumor hypoxia microenvironment orchestrates angiogenesis","volume":"176","author":"Yang","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"key20261020093210_b51-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1054\/bjoc.2000.1396","article-title":"Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissues","volume":"83","author":"Akagi","year":"2000","journal-title":"Br J Cancer"},{"key":"key20261020093210_b52-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"112146","DOI":"10.1016\/j.yexcr.2020.112146","article-title":"Extracellular vesicles derived from macrophage promote angiogenesis in vitro and accelerate new vasculature formation in vivo","volume":"394","author":"Gangadaran","year":"2020","journal-title":"Exp Cell Res"},{"key":"key20261020093210_b53-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.3390\/ijms19071987","article-title":"Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data","volume":"19","author":"Pickart","year":"2018","journal-title":"Int J Mol Sci"},{"key":"key20261020093210_b54-ol-32-5-15857","first-page":"100422","article-title":"Tumor angiogenesis: Current challenges and therapeutic opportunities","volume":"28","author":"Al-Ostoot","year":"2021","journal-title":"Cancer Treat Res Commun"},{"key":"key20261020093210_b55-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s40364-024-00646-1","article-title":"Metabolic reprogramming and immune evasion: the interplay in the tumor microenvironment","volume":"12","author":"Zhang","year":"2024","journal-title":"Biomark Res"},{"key":"key20261020093210_b56-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"1595162","DOI":"10.3389\/fimmu.2025.1595162","article-title":"Research progress on the interaction between glucose metabolic reprogramming and lactylation in tumors","volume":"16","author":"Yang","year":"2025","journal-title":"Front Immunol"},{"key":"key20261020093210_b57-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"790","DOI":"10.7150\/ijms.105553","article-title":"The role of HK2 in tumorigenesis and development: Potential for targeted therapy with natural products","volume":"22","author":"He","year":"2025","journal-title":"Int J Med Sci"},{"key":"key20261020093210_b58-ol-32-5-15857","first-page":"99","article-title":"Pyruvate kinase type M2: A key regulator within the tumour metabolome and a tool for metabolic profiling of tumours","author":"Mazurek","year":"2007","journal-title":"Ernst Schering Found Symp Proc"},{"key":"key20261020093210_b59-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.semcancer.2022.11.007","article-title":"Role of LDH in tumor glycolysis: Regulation of LDHA by small molecules for cancer therapeutics","volume":"87","author":"Sharma","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"key20261020093210_b60-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3390\/diagnostics10070443","article-title":"Clinical perspective and translational oncology of liquid biopsy","volume":"10","author":"Fern\u00e1ndez-L\u00e1zaro","year":"2020","journal-title":"Diagnostics (Basel)"},{"key":"key20261020093210_b61-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"e70017","DOI":"10.1002\/jex2.70017","article-title":"Mechanisms of extracellular vesicle uptake and implications for the design of cancer therapeutics","volume":"3","author":"Jackson Cullison","year":"2024","journal-title":"J Extracell Biol"},{"key":"key20261020093210_b62-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/s41392-020-00258-9","article-title":"Application of exosomes as liquid biopsy in clinical diagnosis","volume":"5","author":"Zhou","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"key20261020093210_b63-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0223-5","article-title":"Extracellular vesicle-based therapeutics: Natural versus engineered targeting and trafficking","volume":"51","author":"Murphy","year":"2019","journal-title":"Exp Mol Med"},{"key":"key20261020093210_b64-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"100084","DOI":"10.1016\/j.ntm.2025.100084","article-title":"Liquid biopsy based on EV biomarkers: A new frontier for early diagnosis and prognosis assessment of cancer at ESMO 2024","volume":"4","author":"Shan","year":"2025","journal-title":"Nano TransMed"},{"key":"key20261020093210_b65-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1080\/10286020.2025.2544144","article-title":"Yatein-induced DNA damage of breast cancer cells by interfering with DNA topoisomerase II\u03b1","volume":"28","author":"Liu","year":"2026","journal-title":"J Asian Nat Prod Res"},{"key":"key20261020093210_b66-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"589","DOI":"10.5582\/bst.2025.01142","article-title":"Exosome-based liquid biopsy: A new frontier in early cancer diagnosis","volume":"19","author":"Li","year":"2025","journal-title":"Biosci Trends"},{"key":"key20261020093210_b67-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13036-024-00470-z","article-title":"Stabilizing milk-derived extracellular vesicles (mEVs) through lyophilization: A novel trehalose and tryptophan formulation for maintaining structure and bioactivity during long-term storage","volume":"19","author":"Dogan","year":"2025","journal-title":"J Biol Eng"},{"key":"key20261020093210_b68-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41568-025-00847-2","article-title":"Advancing engineering design strategies for targeted cancer nanomedicine","volume":"25","author":"Gomerdinger","year":"2025","journal-title":"Nat Rev Cancer"},{"key":"key20261020093210_b69-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"3831","DOI":"10.1038\/s41598-025-87895-8","article-title":"TOP2A inhibition and its cellular effects related to cell cycle checkpoint adaptation pathway","volume":"15","author":"Arroyo","year":"2025","journal-title":"Sci Rep"},{"key":"key20261020093210_b70-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"21533","DOI":"10.1038\/s41598-021-00958-4","article-title":"Nucleolar translocation of human DNA topoisomerase II by ATP depletion and its disruption by the RNA polymerase I inhibitor BMH-21","volume":"11","author":"Morotomi-Yano","year":"2021","journal-title":"Sci Rep"},{"key":"key20261020093210_b71-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s41416-025-03244-6","article-title":"Proteomics analysis of serum extracellular vesicle identifies UCHL1 as a potential therapeutic target for high grade serous ovarian cancer","volume":"134","author":"Lokman","year":"2026","journal-title":"Br J Cancer"},{"key":"key20261020093210_b72-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1007\/s12672-025-04051-4","article-title":"The analysis of TOP2A as a potential target for predicting the prognosis of brain glioma in the TCGA database and in single-center study","volume":"16","author":"Shen","year":"2025","journal-title":"Discov Oncol"},{"key":"key20261020093210_b73-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"14741","DOI":"10.18632\/oncotarget.10819","article-title":"Targeting multidrug-resistant ovarian cancer through estrogen receptor \u03b1 dependent ATP depletion caused by hyperactivation of the unfolded protein response","volume":"9","author":"Zheng","year":"2016","journal-title":"Oncotarget"},{"key":"key20261020093210_b74-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3390\/futurepharmacol5030048","article-title":"Extracellular vesicles as mediators of intercellular communication: Implications for drug discovery and targeted therapies","volume":"5","author":"Mimi","year":"2025","journal-title":"Future Pharmacol"},{"key":"key20261020093210_b75-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"117486","DOI":"10.1016\/j.bmc.2023.117486","article-title":"The mechanisms of multidrug resistance of breast cancer and research progress on related reversal agents","volume":"95","author":"Yu","year":"2023","journal-title":"Bioorg Med Chem"},{"key":"key20261020093210_b76-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.3390\/s26041139","article-title":"Electrochemical biosensors for cancer diagnosis and prognosis using protein biomarkers: Current trends, advances, and clinical translation potential","volume":"26","author":"L\u00f3pez Mujica","year":"2026","journal-title":"Sensors (Basel)"},{"key":"key20261020093210_b77-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"1835580","DOI":"10.3389\/fonc.2026.1835580","article-title":"Evolution of the prostate cancer diagnostic paradigm: integrated evidence and clinical pathways from targeted biopsy to biopsy-free strategy","volume":"16","author":"Liu","year":"2026","journal-title":"Front Oncol"},{"key":"key20261020093210_b78-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.7150\/thno.52570","article-title":"Engineering exosomes for targeted drug delivery","volume":"11","author":"Liang","year":"2021","journal-title":"Theranostics"},{"key":"key20261020093210_b79-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"6680","DOI":"10.1038\/s41467-024-50950-5","article-title":"Reprogramming the tumor immune microenvironment using engineered dual-drug loaded Salmonella","volume":"15","author":"Nguyen","year":"2024","journal-title":"Nat Commun"},{"key":"key20261020093210_b80-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41577-019-0218-4","article-title":"Tumour-intrinsic resistance to immune checkpoint blockade","volume":"20","author":"Kalbasi","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"key20261020093210_b81-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41565-024-01774-3","article-title":"Harnessing extracellular vesicle heterogeneity for diagnostic and therapeutic applications","volume":"20","author":"Carney","year":"2025","journal-title":"Nat Nanotechnol"},{"key":"key20261020093210_b82-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"100185","DOI":"10.1016\/j.celbio.2025.100185","article-title":"mRNA-based technology for engineered regenerative medicine","volume":"2","author":"Zhen","year":"2026","journal-title":"Cell Biomaterials"},{"key":"key20261020093210_b83-ol-32-5-15857","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/s44222-026-00405-x","article-title":"The status of extracellular vesicles as drug carriers and therapeutics","volume":"4","author":"Chaudhari","year":"2026","journal-title":"Nat Rev Bioeng"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T06:32:18Z","timestamp":1792477938000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2026.15857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":83,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,9,11]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2026.15857","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]}}}